Nah, that valuation was based on the Glypromate Clinical Development Programme, which has now been shelved.
NNZ2566 is a spin off of Glypromate anyway.
The only way you will see this share price motor again is if they get to stage 3 trials.
accumulation strong, page-55
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.01 |
Change
-0.010(0.08%) |
Mkt cap ! $1.662B | |||
| Open | High | Low | Value | Volume |
| $13.06 | $13.26 | $12.81 | $5.865M | 451.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 14541 | $13.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.02 | 2438 | 1 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |